Whyrashi Scratchamucho

THE BIOTECH GOLD RUSH IS COMING. GENESISL1 BUILDS THE SHOVELS. ⛏️ In every gold rush, the biggest fortunes were made not by those who dug, but by those who supplied the shovels and tools. The biotech gold rush is starting now. GenesisL1 runs the supply store, the first of its kind: on-chain, public, and open to every lab, every researcher and every AI agent. ━━━━━━━━━━━━ WHY NOW AI designs proteins, peptides and drugs faster than any lab can check them. Results are cheap; proof is scarce. That is the real demand of this rush: data you can verify, models you can replay, IP you can protect, and a record nobody can rewrite. ━━━━━━━━━━━━ LIVE TODAY • MolNFT: 1M+ molecular records, with 229,000+ PDB structures held in full in chain state • GL1F (GenesisL1 Forest): machine learning models as NFTs, with deterministic on-chain inference • CIPNFT: encrypted IP with post-quantum protection • gl1x.com/bio: a decentralized bioinformatics laboratory inside the explorer ━━━━━━━━━━━━ BUILT FOR AI AGENTS Much of the digging in this rush will be done by agents, not by people. GenesisL1 is equipped for them. • Tooling: 80+ tools served over MCP, 40+ of them pure bioinformatics • Sequence and structure: BLAST across 1.2M+ protein sequences, HMMER, MSA, structure search and alignment • Analysis: pockets, ligands, mutation scans, variant effects, proteomics, PubMed • Full workflow: an agent can search, build a training dataset, run an on-chain model, and prove its input data from chain state at a pinned block In development: GL1AI, an open inference market with an OpenAI-compatible API and x402 machine payments, so agents can buy compute on their own. An agent's work here can be checked, not just believed. ━━━━━━━━━━━━ PEPTL (IN DEVELOPMENT) Peptides are one of the richest veins of this rush. PEPTL is a peptide design and docking studio built on the whole stack: MolNFT for structures, GL1F and GL1AI for models. 1. Targets come straight from chain state as MolNFT objects. 2. Design and docking run as in silico experiments in the studio. 3. Results are published to the same chain, public or sealed with CIPNFT. Every experiment is preserved, so a design carries its evidence with it. ━━━━━━━━━━━━ GL1-SEQ: GIT FOR GENOMES 🧬 This month The Bioinformatics Company presents GL1-seq, with a preprint. The idea: manage biological sequence the way git manages code. Today a genome travels as one huge file. Change one base and every pipeline starts from zero. Nobody can prove which version of which sequence produced a result. How GL1-seq works: 1. Canonical encoding Every sequence has exactly one valid encoding: about 2 bits per base for DNA, with compact codes for proteins. Reconstruction is lossless and bit-exact. 2. Content-defined chunks The sequence is cut at anchors chosen by the sequence itself, not by position. Insert one base and only the adjacent chunks are re-cut. Everything else is reused as is. 3. Merkle tree Chunks are hashed into a tree, and the root is the sequence's identifier. Same sequence, same ID, on any machine, in any language, on-chain or off-chain. 4. Edits as deltas A new genome is the reference plus a delta. An edit, a slice, a duplication or a translocation rebuilds only the seams, never the whole genome. 5. Certificates Every edit and every liftover between assemblies carries a certificate sized by the change, not by the genome. Anyone holding only the original identifier can verify it, and so can the chain. Large changes are posted as bonded claims that anyone can challenge, and a dispute comes down to checking a single symbol. 6. Git-style history Commits, branches, merges and conflict reports. Annotation layers travel with the sequence, so genes are lifted from one version to the next and proteins re-derived with a verifiable receipt. 7. Partial reads with proof Read any region of any genome with proof that it belongs there, without downloading the genome. What goes into GenesisL1 chain state: • The human reference genome (GRCh38), in full • Every other genome as a delta against it: 10–20 MB per human genome • 12 pilot genomes at launch, 1000+ public genomes in the months after • The whole human GENCODE annotation, for gene-by-gene comparison and alignment • The human proteome and protein atlases: Swiss-Prot, RefSeq, UniRef50, paired antibody repertoires The result: • More than 7× faster than full recompute • Implementations in Python, JavaScript, Go and C++ that produce identical identifiers • An MCP interface for AI agents from day one Private data never goes on-chain. It stays in each institution's own compliant environment. The chain holds only cryptographic commitments: a provenance and audit layer. ━━━━━━━━━━━━ THE STORE IS OPEN Mainnet live since 2021. No founder, team or investor allocation. No token sale. The tools and supplies are public infrastructure, so any lab, any researcher and any agent can walk in and equip itself today. The rush is starting. The tools are on the shelf. ⛏️ genesisl1.com | gl1x.com/bio #GenesisL1 #DeSci #Biotech #Biotechnology #Bioinformatics #AIAgent #Peptide #TechBio #AIAgents #OnChainAI #BioFi #Web3 #BiotechGoldRush #AgenticAI #DecentralizedScience #SyntheticBiology #MachineLearning #GL1